Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	TCF20 ARID1A TDRD3 TSC22D1 KMT2D MTA1 MED12L MAML2 MAML3 MED12	3.19e-05	303	131	10	GO:0003713
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	MYC WASL ZEB1 TCF20 RIPK1 NFKBIZ PRDM4 FOXJ3 AR TSC22D1 PRDM10 KMT2D ARID2 ZNF335 MED12L CHCHD2 KMT2A ZNF808 MAML2 MAML3 MED12 MYB NOBOX	1.59e-05	1390	129	23	GO:0045944
MousePheno	abnormal forebrain morphology	MICAL1 SP4 NMNAT2 ZEB1 TCF20 ARFGEF1 ELP1 ARID1A CSMD3 LYST NEDD9 KMT2D CSF1R FUBP1 PCDH19 FES ROBO1 DMD MLST8 BAG6 PRRC2B CA1 HTT EPHA4	1.16e-06	1072	106	24	MP:0000783
MousePheno	abnormal telencephalon morphology	MICAL1 SP4 NMNAT2 ZEB1 TCF20 ARFGEF1 ELP1 CSMD3 LYST NEDD9 KMT2D CSF1R FUBP1 FES ROBO1 MLST8 BAG6 CA1 HTT EPHA4	2.55e-06	812	106	20	MP:0000787
MousePheno	absent heartbeat	SP4 WASL ELP1 ARID1A	3.49e-05	25	106	4	MP:0004086
MousePheno	hemorrhage	SMG1 NMNAT2 ABCA3 ZEB1 ARID1A CSMD3 BIRC6 CRK IFNAR1 FUBP1 ARID2 FES KMT2A MLST8 PRRC2B MYB	3.82e-05	664	106	16	MP:0001914
MousePheno	abnormal cerebral hemisphere morphology	MICAL1 SP4 TCF20 ARFGEF1 CSMD3 LYST NEDD9 KMT2D CSF1R FUBP1 FES ROBO1 CA1 HTT EPHA4	4.42e-05	599	106	15	MP:0008540
Domain	Med12	MED12L MED12	4.59e-05	2	127	2	PF09497
Domain	Mediator_Med12_catenin-bd	MED12L MED12	4.59e-05	2	127	2	IPR021989
Domain	Med12-PQL	MED12L MED12	4.59e-05	2	127	2	PF12144
Domain	Med12-LCEWAV	MED12L MED12	4.59e-05	2	127	2	PF12145
Domain	Med12	MED12L MED12	4.59e-05	2	127	2	SM01281
Domain	Mediator_Med12	MED12L MED12	4.59e-05	2	127	2	IPR019035
Domain	Mediator_Med12_LCEWAV	MED12L MED12	4.59e-05	2	127	2	IPR021990
Domain	MamL-1	MAML2 MAML3	1.37e-04	3	127	2	SM01275
Domain	Neuroggenic_mastermind-like_N	MAML2 MAML3	1.37e-04	3	127	2	IPR019082
Domain	SUZ	ARPP21 R3HDM1	1.37e-04	3	127	2	PF12752
Domain	MamL-1	MAML2 MAML3	1.37e-04	3	127	2	PF09596
Domain	TSC-22_Dip_Bun	TSC22D2 TSC22D1	2.73e-04	4	127	2	IPR000580
Domain	SUZ	ARPP21 R3HDM1	2.73e-04	4	127	2	IPR024771
Domain	TSC-22_Dip_Bun	TSC22D2 TSC22D1	2.73e-04	4	127	2	PD007152
Domain	SUZ	ARPP21 R3HDM1	2.73e-04	4	127	2	PS51673
Domain	TSC22	TSC22D2 TSC22D1	2.73e-04	4	127	2	PF01166
Domain	TSC22	TSC22D2 TSC22D1	2.73e-04	4	127	2	PS01289
Domain	SET_dom	PRDM4 PRDM10 KMT2D KMT2A	3.69e-04	50	127	4	IPR001214
Domain	SET	PRDM4 PRDM10 KMT2D KMT2A	3.69e-04	50	127	4	PS50280
Domain	FCH	FNBP1 PSTPIP1 FES	4.30e-04	22	127	3	PF00611
Domain	EPHD	TCF20 KMT2D KMT2A	4.30e-04	22	127	3	PS51805
Domain	FCH	FNBP1 PSTPIP1 FES	4.30e-04	22	127	3	SM00055
Domain	FYrich_C	KMT2D KMT2A	4.53e-04	5	127	2	IPR003889
Domain	FYrich_N	KMT2D KMT2A	4.53e-04	5	127	2	IPR003888
Domain	FYRC	KMT2D KMT2A	4.53e-04	5	127	2	SM00542
Domain	FYRN	KMT2D KMT2A	4.53e-04	5	127	2	SM00541
Domain	FYRN	KMT2D KMT2A	4.53e-04	5	127	2	PF05964
Domain	FYRC	KMT2D KMT2A	4.53e-04	5	127	2	PF05965
Domain	FYRC	KMT2D KMT2A	4.53e-04	5	127	2	PS51543
Domain	FYRN	KMT2D KMT2A	4.53e-04	5	127	2	PS51542
Domain	FCH_dom	FNBP1 PSTPIP1 FES	4.92e-04	23	127	3	IPR001060
Domain	F_BAR	FNBP1 PSTPIP1 FES	6.33e-04	25	127	3	IPR031160
Domain	F_BAR	FNBP1 PSTPIP1 FES	6.33e-04	25	127	3	PS51741
Domain	R3H	ARPP21 R3HDM1	1.60e-03	9	127	2	SM00393
Pubmed	Interaction network of human early embryonic transcription factors.	ZEB1 TCF20 ACACB ARID1A KMT2D ARID2 KMT2A QSER1 MLST8 MED12 PRRC2B	1.29e-07	351	134	11	38297188
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FNBP1 SMG1 TCF20 ACACB TTC28 ELP1 MUC16 ARID1A CSMD2 FOXJ3 KMT2D ARID2 MAML3 PRRC2B	1.92e-07	638	134	14	31182584
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	TCF20 ARID1A AR KMT2D MTA1 FUBP1 ARID2 MED12 HNRNPR	2.03e-07	220	134	9	35785414
Pubmed	Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription.	MYC CSF1R MYB	2.23e-07	4	134	3	3110291
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TCF20 TTC28 DBNL ARID1A CRK KMT2D ARID2 DOCK7 KMT2A QSER1 MED12 PRRC2B HTT	2.28e-07	549	134	13	38280479
Pubmed	Genetic interaction mapping in mammalian cells using CRISPR interference.	ELP1 ARID1A KMT2D MTA1 KMT2A MED12	2.87e-07	69	134	6	28481362
Pubmed	Human transcription factor protein interaction networks.	MYC SMG1 ZEB1 TCF20 ACACB SEC24A MYO18A ARID1A KMT2D MTA1 FUBP1 ARID2 ZNF611 KMT2A EIF3A QSER1 R3HDM1 PRRC2B MYB HNRNPR	6.11e-07	1429	134	20	35140242
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	SMG1 SEC24A ARFGEF1 ARID1A CRK KMT2A ATP6V1C2 HTT	6.75e-07	186	134	8	33637726
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SQLE TSC22D2 PRDM4 BIRC6 TTK MSTO1 CRK PRDM10 ARID2 SCAPER KMT2A LTBP1 MAML2 R3HDM1 MLST8 BAG6 MED12 HTT HNRNPR	8.59e-07	1327	134	19	32694731
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	TCF20 TTC28 SEC24A FAM171B ARID1A TTK MEIOC R3HDM1 PRRC2B	9.04e-07	263	134	9	34702444
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MYC SP4 ACACB TSC22D2 PRDM4 FOXJ3 CRK NEDD9 MTA1 ARID2 MAML2	9.57e-07	430	134	11	35044719
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	SMG1 MUC16 ITGA2 PSTPIP1 LYST MSTO1 KMT2D CLCA2 ZNF335 NAV2 RBM38 NOL8	1.65e-06	552	134	12	10737800
Pubmed	MICAL, a novel CasL interacting molecule, associates with vimentin.	MICAL1 CRK NEDD9	1.94e-06	7	134	3	11827972
Pubmed	Coordination between the actin cytoskeleton and membrane deformation by a novel membrane tubulation domain of PCH proteins is involved in endocytosis.	FNBP1 WASL PSTPIP1	1.94e-06	7	134	3	16418535
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ACACB TTC28 BMP2K SEC24A ARFGEF1 MUC16 FAM171B TFG BIRC6 PKHD1L1 DOCK7 ROBO1 PRRC2B NOL8	1.98e-06	777	134	14	35844135
Pubmed	The mutational landscape of lethal castration-resistant prostate cancer.	AR KMT2D KMT2A	3.09e-06	8	134	3	22722839
Pubmed	A human MAP kinase interactome.	MYC WASL TCF20 RIPK1 MYO18A TSC22D1 ARID2 NAV2 ROBO1 EIF3A DMD	3.11e-06	486	134	11	20936779
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MYC SP4 ZEB1 TCF20 NFKBIZ ARID1A PRDM4 FOXJ3 PKHD1L1 TSC22D1 ARID2 SCAPER MYB NOBOX	3.12e-06	808	134	14	20412781
Pubmed	An investigation into the human serum "interactome".	QTRT2 ITGA2 ERVK-10 TSC22D1 CLCA2 PLA2G4F DMD	3.34e-06	162	134	7	15174051
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B FNBP1 TCF20 TTC28 CSMD3 PCDH19 DOCK7 R3HDM1 TMEM181 PRRC2B	4.34e-06	407	134	10	12693553
Pubmed	Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation.	IFNAR1 SIGLEC10 SIGLEC11	4.62e-06	9	134	3	23374343
Pubmed	Gender- and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice.	MYC AR MYB	4.62e-06	9	134	3	10619357
Pubmed	Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.	MYC KMT2D KMT2A	4.62e-06	9	134	3	26691508
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZEB1 TCF20 ACACB TTC28 BIRC6 MSTO1 CRK KMT2D DOCK7 MED12	5.48e-06	418	134	10	34709266
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	FNBP1 SP4 TCF20 ARID1A FOXJ3 KMT2D MTA1 FUBP1 ARID2 KMT2A QSER1 BAG6 MED12 PRRC2B MYB HNRNPR	5.75e-06	1103	134	16	34189442
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TCF20 TTC28 SEC24A DBNL PTPN21 TTK LYST CDC14A DOCK7 NAV2 KMT2A R3HDM1 WNK3 KLC3	6.43e-06	861	134	14	36931259
Pubmed	Expression of cellular oncogenes during embryonic and fetal development of the mouse.	MYC FES MYB	6.58e-06	10	134	3	6594688
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TCF20 ARID1A AR KMT2D KMT2A QSER1 MED12 PRRC2B	1.01e-05	268	134	8	33640491
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TCF20 SEC24A ARID1A TFG KMT2D MEIOC FUBP1 QSER1 MAML3 PRRC2B	1.19e-05	457	134	10	32344865
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	FNBP1 ARPP21 RIPK1 DBNL NEDD9 R3HDM1	1.34e-05	133	134	6	15144186
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SEC24A ELP1 PTPN21 FAM171B ARID1A BIRC6 CDC14A PHKB PTPDC1 TDRD3 KMT2D ROBO1 LTBP1 DMD PRRC2B	1.36e-05	1049	134	15	27880917
Pubmed	Triad3a induces the degradation of early necrosome to limit RipK1-dependent cytokine production and necroptosis.	RIPK1 RNF216	1.47e-05	2	134	2	29789521
Pubmed	Androgen receptor is overexpressed in boys with severe hypospadias, and ZEB1 regulates androgen receptor expression in human foreskin cells.	ZEB1 AR	1.47e-05	2	134	2	22391641
Pubmed	Expression of far upstream element-binding protein 1 correlates with c-Myc expression in sacral chordomas and is associated with tumor progression and poor prognosis.	MYC FUBP1	1.47e-05	2	134	2	28780352
Pubmed	F-actin binding regions on the androgen receptor and huntingtin increase aggregation and alter aggregate characteristics.	AR HTT	1.47e-05	2	134	2	20140226
Pubmed	Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation.	MYC AR	1.47e-05	2	134	2	23704919
Pubmed	A common motif targets huntingtin and the androgen receptor to the proteasome.	AR HTT	1.47e-05	2	134	2	18586675
Pubmed	Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion.	AR TREM1	1.47e-05	2	134	2	32908142
Pubmed	Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.	MYC MYB	1.47e-05	2	134	2	11848471
Pubmed	First case of B ALL with KMT2A-MAML2 rearrangement: a case report.	KMT2A MAML2	1.47e-05	2	134	2	28535805
Pubmed	Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.	MYC AR	1.47e-05	2	134	2	34911936
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2D KMT2A	1.47e-05	2	134	2	24423662
Pubmed	Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.	MYC FUBP1	1.47e-05	2	134	2	24347226
Pubmed	Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc.	MYC FUBP1	1.47e-05	2	134	2	35546072
Pubmed	MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer.	AR MYB	1.47e-05	2	134	2	34837075
Pubmed	A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer.	MYC AR	1.47e-05	2	134	2	30820039
Pubmed	Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.	MYC KMT2A	1.47e-05	2	134	2	27318442
Pubmed	Presence of regulatory sequences within intron 4 of human and murine c-myb genes.	MYC MYB	1.47e-05	2	134	2	7918623
Pubmed	LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.	MYC FUBP1	1.47e-05	2	134	2	34274028
Pubmed	Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.	MYC MTA1	1.47e-05	2	134	2	16172399
Pubmed	ZEB1 protects skeletal muscle from damage and is required for its regeneration.	ZEB1 DMD	1.47e-05	2	134	2	30910999
Pubmed	The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns.	ELFN2 ELFN1	1.47e-05	2	134	2	17868438
Pubmed	Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.	ZEB1 MYB	1.47e-05	2	134	2	24283570
Pubmed	Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.	ZEB1 AR	1.47e-05	2	134	2	19921427
Pubmed	Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.	IFNAR1 DNASE2	1.47e-05	2	134	2	17066036
Pubmed	Neuroinvasiveness of the MR766 strain of Zika virus in IFNAR-/- mice maps to prM residues conserved amongst African genotype viruses.	IFNAR1 DNASE2	1.47e-05	2	134	2	34310650
Pubmed	The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.	MYC FUBP1	1.47e-05	2	134	2	34116677
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2D KMT2A	1.47e-05	2	134	2	26711341
Pubmed	Far Upstream Element Binding Protein Plays a Crucial Role in Embryonic Development, Hematopoiesis, and Stabilizing Myc Expression Levels.	MYC FUBP1	1.47e-05	2	134	2	26774856
Pubmed	MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.	MYC AR	1.47e-05	2	134	2	35562350
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	1.47e-05	2	134	2	23544943
Pubmed	The dynamic response of upstream DNA to transcription-generated torsional stress.	MYC FUBP1	1.47e-05	2	134	2	15502847
Pubmed	KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.	KMT2A MAML2	1.47e-05	2	134	2	34550633
Pubmed	MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix.	DBNL MUC4	1.47e-05	2	134	2	9858486
Pubmed	Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.	MYC AR	1.47e-05	2	134	2	26231735
Pubmed	Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions.	MYC AR	1.47e-05	2	134	2	37828515
Pubmed	c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation.	MYC MYB	1.47e-05	2	134	2	12525485
Pubmed	Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.	MYC FUBP1	1.47e-05	2	134	2	26490982
Pubmed	Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.	AR MTA1	1.47e-05	2	134	2	27026268
Pubmed	MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.	MYC AR	1.47e-05	2	134	2	37815914
Pubmed	[Expression of c-myc and c-myb gene in leukemic bone marrow stromal cells and their correlation].	MYC MYB	1.47e-05	2	134	2	22739149
Pubmed	Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure.	CHCHD2 HTT	1.47e-05	2	134	2	39174523
Pubmed	Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.	MYC MYB	1.47e-05	2	134	2	1588953
Pubmed	The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.	MYC RBM38	1.47e-05	2	134	2	28399911
Pubmed	Localization of murine X and autosomal sequences homologous to the human Y located testis-determining region.	AR DMD MYB	1.55e-05	13	134	3	2721933
Pubmed	Impact of WIN site inhibitor on the WDR5 interactome.	MYC KMT2D KMT2A MLST8	2.31e-05	43	134	4	33472061
Pubmed	The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver.	MYC SIGLEC10 SIGLEC11	2.46e-05	15	134	3	22496360
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	WASL BMP2K DBNL MYO18A TTK TDRD3 MTA1 DOCK7 R3HDM1 PRRC2B NOL8 HNRNPR	2.52e-05	724	134	12	36232890
Pubmed	Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.	CSMD2 FUBP1 KMT2A ROBO1 PRRC2B	2.66e-05	90	134	5	15033168
Pubmed	Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.	ITGA2 TSC22D2 ARID2 WNK3	2.78e-05	45	134	4	27337956
Pubmed	Application of gene network analysis techniques identifies AXIN1/PDIA2 and endoglin haplotypes associated with bicuspid aortic valve.	ELP1 CSF1R BAG6	3.02e-05	16	134	3	20098615
Pubmed	Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling.	MAML2 MAML3	4.41e-05	3	134	2	12386158
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	4.41e-05	3	134	2	23053434
Pubmed	Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP.	TCF20 AR	4.41e-05	3	134	2	21935435
Pubmed	MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.	MYC MUC16	4.41e-05	3	134	2	26046375
Pubmed	Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.	MYC AR	4.41e-05	3	134	2	25893287
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2D KMT2A	4.41e-05	3	134	2	23932714
Pubmed	RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia.	MYC MYB	4.41e-05	3	134	2	28790107
Pubmed	The scaffold protein menin is essential for activating the MYC locus and MYC-mediated androgen receptor transcription in androgen receptor-dependent prostate cancer cells.	MYC AR	4.41e-05	3	134	2	34850609
Pubmed	Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains.	MYC MYB	4.41e-05	3	134	2	3505665
Pubmed	Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.	MYC AR	4.41e-05	3	134	2	21781227
Pubmed	RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression.	MYC AR	4.41e-05	3	134	2	35428760
Pubmed	T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G.	CRK NEDD9	4.41e-05	3	134	2	9497377
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	4.41e-05	3	134	2	24939955
Pubmed	ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.	ARID1A ARID2	4.41e-05	3	134	2	34512623
Pubmed	A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.	MUC4 MYB	4.41e-05	3	134	2	25522282
Pubmed	MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.	MYC AR	4.41e-05	3	134	2	22128178
Pubmed	Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23).	MYC KMT2A	4.41e-05	3	134	2	16328057
Pubmed	Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.	ARID1A ARID2	4.41e-05	3	134	2	26716708
Pubmed	STING Contributes to Abnormal Bone Formation Induced by Deficiency of DNase II in Mice.	IFNAR1 DNASE2	4.41e-05	3	134	2	27740718
Interaction	CRX interactions	SP4 TCF20 ARID1A TFG KMT2D ARID2 QSER1 MED12 PRRC2B CA8	6.43e-06	254	131	10	int:CRX
Interaction	RUNX1 interactions	MYC ARID1A PRDM4 AR MSTO1 MTA1 FUBP1 KMT2A EIF3A MED12 HNRNPR	8.94e-06	324	131	11	int:RUNX1
Interaction	MED23 interactions	MYC TTC28 FOXJ3 AR PHKB DOCK7 MED12L LTBP1 BAG6 MED12	9.63e-06	266	131	10	int:MED23
Interaction	IRF4 interactions	TCF20 ELP1 ARID1A KMT2D ARID2 PRRC2B	1.93e-05	85	131	6	int:IRF4
Interaction	WWTR1 interactions	ZEB1 TCF20 TTC28 DBNL ARID1A KMT2D ARID2 DOCK7 KMT2A QSER1 PRRC2B HTT	2.04e-05	422	131	12	int:WWTR1
Interaction	PRMT2 interactions	WASL TTC28 R3HDM1 CHCHD2P9 BAG6 HTT	2.85e-05	91	131	6	int:PRMT2
Interaction	CCNH interactions	MYC TFG AR MTA1 FUBP1 KLC3	4.34e-05	98	131	6	int:CCNH
Interaction	KDM5B interactions	MYC BMP2K DBNL AR KMT2A HTT	4.86e-05	100	131	6	int:KDM5B
Interaction	FEV interactions	ZEB1 TCF20 ARID1A KMT2D ARID2 KMT2A QSER1 PRRC2B	5.54e-05	203	131	8	int:FEV
GeneFamily	CDC14 phosphatases	CDC14A PTPDC1	1.53e-04	4	92	2	900
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	FNBP1 PSTPIP1 FES	2.10e-04	23	92	3	1288
GeneFamily	Ataxins\|Trinucleotide repeat containing	KMT2D MAML3 MED12	2.70e-04	25	92	3	775
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	FNBP1 SP4 LRP12 NMNAT2 ABCA3 ARPP21 APBA1 ARFGEF1 FAM171B CSMD2 CSMD3 LYST PCDH19 ROBO1 R3HDM1 TMEM178B WNK3 PRRC2B CA1	2.32e-06	1106	130	19	M39071
Coexpression	GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN	TCF20 TSC22D2 CDC14A HERC2P3 TDRD3 EIF3A RBM38 EPHA4	7.32e-06	200	130	8	M8306
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MYC ZEB1 TTC28 BMP2K SEC24A ARFGEF1 TSC22D2 FOXJ3 TTK TDRD3 FUBP1 EIF3A DMD R3HDM1 EPHA4	2.34e-05	856	130	15	M4500
Coexpression	GEORGES_TARGETS_OF_MIR192_AND_MIR215	FNBP1 SP4 BMP2K ARFGEF1 NFKBIZ FAM171B PRDM4 TTK CDC14A CRK ORC1 FUBP1 ZNF611 MYB CA8	3.75e-05	892	130	15	M18120
Coexpression	MAHAJAN_RESPONSE_TO_IL1A_UP	MYC RIPK1 AR NEDD9 MYB	4.12e-05	77	130	5	M6154
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	ZEB1 TTC28 NFKBIZ PTPN21 NEDD9 TSC22D1 DOCK7 KMT2A ROBO1 LTBP1 DMD MUC4 KLRG1	6.34e-05	721	130	13	M1999
Coexpression	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	MYC FNBP1 SQLE PHKB KMT2A MLST8 MED12	6.49e-05	200	130	7	M7031
Coexpression	GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP	SMG1 SP4 BMP2K MYO18A LYST NEDD9 FES	6.49e-05	200	130	7	M7831
Coexpression	GSE7852_LN_VS_FAT_TCONV_DN	RIPK1 NFKBIZ TSC22D2 AR ORC1 TSC22D1 KLRG1	6.49e-05	200	130	7	M5748
Coexpression	GSE20715_0H_VS_48H_OZONE_LUNG_UP	MICAL1 ELP1 PSTPIP1 MSTO1 IFNAR1 MED12 HNRNPR	6.49e-05	200	130	7	M4368
Coexpression	LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2	ZEB1 TTC28 NEDD9 TMEM178B MAML3	7.01e-05	86	130	5	M39248
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 ZEB1 NFKBIZ TSC22D2 FOXJ3 CRK LTBP1 EIF3A DMD	4.54e-09	185	132	9	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 BMP2K NFKBIZ TSC22D2 IFNAR1 CSF1R MED12L MAML2	5.45e-08	175	132	8	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP4 STAB2 PSTPIP1 CSMD2 PRDM4 AR KLRG1	4.91e-07	159	132	7	f7bccfeffa737f151417bf52ea45111b0957bce9
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 BMP2K NFKBIZ TSC22D2 IFNAR1 CSF1R MAML2	8.66e-07	173	132	7	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 BMP2K NFKBIZ TSC22D2 IFNAR1 CSF1R MAML2	8.66e-07	173	132	7	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 BMP2K NFKBIZ TSC22D2 IFNAR1 CSF1R MAML2	8.66e-07	173	132	7	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CLDN14 PSTPIP1 TTK FUBP1 RBM38 HNRNPR	1.91e-06	124	132	6	1483be8700eca7e2c288784a290d945d4022b17f
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B TTC28 SCAPER NAV2 MAML2 DMD MAML3	2.13e-06	198	132	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122\|Adult / Lineage, Cell type, age group and donor	ST6GALNAC1 UNC13B ABCA3 ELFN2 ATP6V1C2 CA8	7.48e-06	157	132	6	31d1bd9138c60e8485664ec4144f987226e3eef9
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA3 B4GALNT1 MUC16 SLCO5A1 ROBO1 TMEM178B	1.06e-05	167	132	6	8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6
ToppCell	343B-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	FNBP1 B4GALNT1 ZEB1 SLCO5A1 PCDH19 MED12	1.14e-05	169	132	6	e68e6c24606fd46eca6f86bb63fa86ea17879ae2
ToppCell	facs-Skin-nan-24m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DBNL NFKBIZ TTK CLCA2 NAV2 PLA2G4F	1.26e-05	172	132	6	5ca89af7406e7e1a055dd60d6f89615f69e62324
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 FAM171B PRDM4 SLCO5A1 PRRC2B NOL8	1.30e-05	173	132	6	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 FAM171B PRDM4 SLCO5A1 PRRC2B NOL8	1.30e-05	173	132	6	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	COVID-19_Mild-Neu_3\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	SEC24A SQLE ELP1 TSC22D2 KMT2D DNASE2	1.43e-05	176	132	6	2049767fd591045cfcf5b1071d80798e52843f27
ToppCell	PBMC-Mild-cDC_11\|Mild / Compartment, Disease Groups and Clusters	FNBP1 ITGA2 SLCO5A1 SIGLEC10 ATP6V1C2 DMD	1.48e-05	177	132	6	974305e4c0eff90134c4e58cf11b955d1eee0501
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	ARPP21 MYO18A CSMD3 ELFN2 SCAPER KMT2A	1.48e-05	177	132	6	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP12 FBXL13 SQLE APBA1 IFNAR1 TSC22D1	1.53e-05	178	132	6	742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ITGA2 FAM171B TSC22D1 MED12L CA1 MYB	1.63e-05	180	132	6	2694f5deaed551c53e74d8a9fbd41d3734bb9f37
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ITGA2 FAM171B TSC22D1 MED12L CA1 MYB	1.63e-05	180	132	6	ef0de602fc8ccfd32a06978ac0100afe0ce1beeb
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC1 MUC16 AR CLCA2 MUC4 CA8	1.73e-05	182	132	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SGCZ FCRL3 LTBP1 CA1 MYB CA8	1.79e-05	183	132	6	f8b636391f752e379a5c5575fd898bdf0907a3b8
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 NFKBIZ BIRC6 LYST KMT2A EIF3A	1.84e-05	184	132	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	TCF20 TTC28 ARID1A ROBO1 R3HDM1 MAML3	1.96e-05	186	132	6	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO5A1 SGCZ LTBP1 CA1 MYB CA8	1.96e-05	186	132	6	77592a6397b44b2b59a4fc39d7224dd95343efe6
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	TCF20 TTC28 ARID1A ROBO1 R3HDM1 MAML3	1.96e-05	186	132	6	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO5A1 SGCZ LTBP1 CA1 MYB CA8	2.08e-05	188	132	6	8268574584e5fb869a6cb8bbd7135cd7454a6a25
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SMG1 ARFGEF1 BIRC6 CDC14A ARID2 KMT2A	2.08e-05	188	132	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	facs-Pancreas-Endocrine-24m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 NFKBIZ SGCZ TSC22D1 NAV2 PRRC2B	2.14e-05	189	132	6	010fdd70e9d0e21b856306a29ff877776a480319
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO5A1 SGCZ LTBP1 CA1 MYB CA8	2.14e-05	189	132	6	222e67d3fd106c43b0cae6538dddeaa7be1f759f
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MUC16 ITGA2 PKHD1L1 TSC22D1 MUC4 KLC3	2.14e-05	189	132	6	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLCO5A1 SGCZ LTBP1 CA1 MYB CA8	2.21e-05	190	132	6	59720dfe9de1b980807644536c919d2a02ba69dd
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NMNAT2 TTC28 NFKBIZ SGCZ NAV2 PRRC2B	2.27e-05	191	132	6	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SMG1 ARFGEF1 NFKBIZ CDC14A KMT2A MAML2	2.34e-05	192	132	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NMNAT2 TTC28 SQLE SGCZ MUC4 PRRC2B	2.55e-05	195	132	6	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ZEB1 TTC28 NFKBIZ NAV2 ROBO1 MAML2	2.55e-05	195	132	6	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 ARFGEF1 SGCZ SCAPER NAV2 KMT2A	2.55e-05	195	132	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARPP21 CSMD2 TSC22D1 DNAJC5G R3HDM1 EPHA4	2.55e-05	195	132	6	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 ARFGEF1 SGCZ SCAPER NAV2 KMT2A	2.55e-05	195	132	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	TTC28 SCAPER NAV2 MAML2 DMD MAML3	2.63e-05	196	132	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	BAL-Mild-cDC_10\|Mild / Compartment, Disease Groups and Clusters	FNBP1 ZEB1 LYST SLCO5A1 PHKB DMD	2.70e-05	197	132	6	c0550d41dd5619b369b590f3d6a61154dd7b2cab
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	C5orf67 BMP2K SLCO5A1 CSF1R SIGLEC10 MED12	2.70e-05	197	132	6	68d8546dfe7dffd017756a11d3333061f576d0ef
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYC TSC22D1 MED12L WNK3 CA1 MYB	2.78e-05	198	132	6	d5996bd3756fcd4d5866006da2ecd923f0f25427
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYC TSC22D1 MED12L WNK3 CA1 MYB	2.78e-05	198	132	6	8be58e41ae7870d268e7ce5ab937769e2ecb60d9
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BMP2K PKD1L1 PKHD1L1 MED12L CA1 RBM38	2.86e-05	199	132	6	565404c155dfac57c020a8f2d09cbf756da20ffd
ToppCell	Control_saline-Hematopoietic_Lymphocytic-B_cells\|Control_saline / Treatment groups by lineage, cell group, cell type	MYC ARPP21 PSTPIP1 SIGLEC10 CALY RBM38	2.86e-05	199	132	6	a984b83d6e143c1e497726da09d8e1acf1f59a74
ToppCell	Control_saline-Hematopoietic_Lymphocytic-B_cells-B-cells\|Control_saline / Treatment groups by lineage, cell group, cell type	MYC ARPP21 PSTPIP1 SIGLEC10 CALY RBM38	2.86e-05	199	132	6	8913a2f255f42a684221fa0c812e254aa43d8704
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TTC28 BIRC6 SCAPER MAML2 DMD MAML3	2.86e-05	199	132	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ST6GALNAC1 MUC16 ITGA2 CLCA2 TMEM178B MUC4	2.86e-05	199	132	6	f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	ARPP21 CSMD2 CSF1R PCDH19 CALY R3HDM1	2.94e-05	200	132	6	61d7dd0a78942b069c3f5e75044368dc00e6e8e6
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLCO5A1 SGCZ LTBP1 CA1 MYB CA8	2.94e-05	200	132	6	ca5401b76ab014080914bf78042d368cf318effa
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 ARPP21 CSMD2 CSMD3 ELFN2 SGCZ	2.94e-05	200	132	6	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 ARPP21 CSMD2 CSMD3 ELFN2 SGCZ	2.94e-05	200	132	6	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 ARPP21 CSMD2 CSMD3 ELFN2 SGCZ	2.94e-05	200	132	6	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Parenchyma_Control_(B.)-Immune-TX-MoAM-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	BMP2K PSTPIP1 CSF1R SIGLEC10 FES CA8	2.94e-05	200	132	6	670ef1e68be0d2c6ea20ab4dea1d051a3cc89799
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLCO5A1 SGCZ LTBP1 CA1 MYB CA8	2.94e-05	200	132	6	70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SLCO5A1 SGCZ LTBP1 CA1 MYB CA8	2.94e-05	200	132	6	40286010bd17cf9e34ecd5440953b072ebfae208
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 ARPP21 CSMD2 CSMD3 ELFN2 SGCZ	2.94e-05	200	132	6	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 ARPP21 CSMD2 CSMD3 ELFN2 SGCZ	2.94e-05	200	132	6	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	ARPP21 CSMD2 CSF1R PCDH19 CALY R3HDM1	2.94e-05	200	132	6	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ZEB1 ARPP21 CSMD2 CSMD3 ELFN2 SGCZ	2.94e-05	200	132	6	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Myeloid-E_(Neutrophils)\|World / shred on cell class and cell subclass (v4)	PSTPIP1 LYST FES TREM1 MED12L	7.22e-05	145	132	5	6ae7dbc62116b4d0610fb55703679488e8da4733
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	B4GALNT1 CSMD3 ATP6V1C2 WNK3 CA8	7.46e-05	146	132	5	ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	SMG1 ZEB1 CDC14A SCAPER KMT2A	8.75e-05	151	132	5	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PTPN21 AR PTPDC1 CLCA2 DMD	9.02e-05	152	132	5	eb7ff36792c3c54ac88cfe976f84016b70b1a1d7
ToppCell	E15.5-Hematopoietic-Immune-immune_cell_unspecified\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	B4GALNT1 PSTPIP1 CSF1R FES TREM1	1.05e-04	157	132	5	4263627911657e788a1d0230690ee434e8a4f9a1
ToppCell	E15.5-Hematopoietic-Immune\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	B4GALNT1 PSTPIP1 CSF1R FES TREM1	1.05e-04	157	132	5	de689a133863ed74d848eba0a4f392357ac28245
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP4 PSTPIP1 ORC1 TDRD3 KLRG1	1.15e-04	160	132	5	b2d8940ea8c068273b7da1589d3d6ae5110d8209
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP4 PSTPIP1 ORC1 TDRD3 KLRG1	1.15e-04	160	132	5	9caab1bb63c7e66c44783852ee75b16bb40fa594
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP4 PSTPIP1 ORC1 TDRD3 KLRG1	1.15e-04	160	132	5	229841be7b984a00a301cd5d88c11226a90d8a88
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP4 PSTPIP1 ORC1 TDRD3 KLRG1	1.15e-04	160	132	5	99c9ae2041445539fada842e1af01368669bfca0
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	B4GALNT1 MED12L LTBP1 MAML3 CA8	1.18e-04	161	132	5	3e5a125a25d55bf27652f456239b00b315d54d91
ToppCell	10x5'-bone_marrow-Myeloid_Dendritic-DC1\|bone_marrow / Manually curated celltypes from each tissue	APBA1 SLCO5A1 PCDH19 ROBO1 DMD	1.18e-04	161	132	5	2f068ee643de2f647c289779a6624265ab9a749b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	ARID1A CDC14A CSF1R DOCK7 MED12L	1.22e-04	162	132	5	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 C5orf67 ARPP21 MUC16 CLCA2	1.22e-04	162	132	5	112fa4de685727f6c8bf6fc4afb82de0524070ad
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NMNAT2 PCDHB11 SGCZ MLST8 MAML3	1.25e-04	163	132	5	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B0\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	SIGLEC10 LTBP1 QSER1 CA1 CA8	1.33e-04	165	132	5	ebd668e87e5961a124d1d6fc25d1f03e4af05cd4
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D3\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	B4GALNT1 MED12L LTBP1 MAML3 CA8	1.44e-04	168	132	5	6501495b7ad252af330b18011696c43031541018
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLDN14 NEDD9 LTBP1 DMD TMEM178B	1.48e-04	169	132	5	2456b3e7776e8a2214972be1b4d66a3ca5480ae0
ToppCell	343B-Myeloid-Dendritic-cDC_activated\|343B / Donor, Lineage, Cell class and subclass (all cells)	FNBP1 B4GALNT1 BMP2K SLCO5A1 PCDH19	1.48e-04	169	132	5	2098f15a388d019ed7f1d4c209affd5ca2886dcc
ToppCell	wk_20-22-Hematologic-Meg-ery-Megakaryocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LRP12 BEND2 PKHD1L1 MED12L LTBP1	1.52e-04	170	132	5	eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 PSTPIP1 MUC4 MYB CA8	1.52e-04	170	132	5	2c5a1469e5743870e96e6c2cc92f0c5096b79f51
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PCDHB14 AR ROBO1 ATP6V1C2 WNK3	1.52e-04	170	132	5	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ST6GALNAC1 PSTPIP1 MUC4 MYB CA8	1.52e-04	170	132	5	9bea81031cdfe45e8cddac3a3afd9ca6c331c45a
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYC B4GALNT1 SEC24A CLCA2 RBM38	1.57e-04	171	132	5	c6fc9ef9735dbf5314a4c7dac2b2954b0985ae4d
ToppCell	facs-Heart-LV-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYC B4GALNT1 SEC24A CLCA2 RBM38	1.57e-04	171	132	5	55b194a9bf4d3e4b5d96e0d1298424359c441cbb
ToppCell	COVID-19-lung-RBC\|lung / Disease (COVID-19 only), tissue and cell type	PKHD1L1 MED12L LTBP1 CA1 RBM38	1.57e-04	171	132	5	0e8d63c8fbccdda4f1ef00de00667a50464b104b
ToppCell	droplet-Marrow-nan-3m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELP1 NFKBIZ LYST NEDD9 TREM1	1.61e-04	172	132	5	cfcfa7eeff1805bedf10a3c07826459914c3e872
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	NMNAT2 ZEB1 STAB2 PKHD1L1 DNAJC5G	1.61e-04	172	132	5	c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NMNAT2 B4GALNT1 PSTPIP1 KLRG1 RBM38	1.61e-04	172	132	5	f45489e80c59b824846ffda675de0d118a8b850c
ToppCell	E18.5-samps-Epithelial-Alveolar_epithelial-AT2\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ABCA3 PLA2G4F ATP6V1C2 MUC4 CA8	1.65e-04	173	132	5	f6e36ea98a9c669ff393d141455aaecef083f738
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	ST6GALNAC1 MUC16 CLCA2 CA1 CA8	1.70e-04	174	132	5	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV2 ROBO1 LTBP1 MAML2 DMD	1.75e-04	175	132	5	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	mild_COVID-19-pDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	ARPP21 AR MED12L MYB CA8	1.75e-04	175	132	5	b87f279a7519710146c49d6acccb0adedc195965
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DNAJC5G NAV2 ROBO1 MAML2 DMD	1.75e-04	175	132	5	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DNAJC5G NAV2 ROBO1 MAML2 DMD	1.75e-04	175	132	5	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLDN14 ACACB FES NAV2 RBM38	1.75e-04	175	132	5	f24b664b9056b5976bf2222e8013f15c09e049ad
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4\|TCGA-Lung / Sample_Type by Project: Shred V9	NMNAT2 SEC24A ELFN2 IFNAR1 SLCO5A1	1.79e-04	176	132	5	0923b01137d6f9956ca815b41102c81e82624065
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYC B4GALNT1 ITGA2 PSTPIP1 KLRG1	1.79e-04	176	132	5	27c5ddd67de52101360ef7de8fcfa041066d97db
ToppCell	severe-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FBXL13 NEDD9 SIGLEC10 TREM1 MAML2	1.84e-04	177	132	5	d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; HL60; HT_HG-U133A	ITGA2 CDC14A PRDM10 ZNF611 KMT2A QSER1 R3HDM1 DNASE2 EPHA4	2.11e-06	198	130	9	3092_DN
Disease	cognitive function measurement	SP4 NMNAT2 ARPP21 TCF20 TTC28 APBA1 TSC22D2 CSMD3 BIRC6 NEDD9 SGCZ KMT2D ZNF335 TREM1 MED12L RNF216 LTBP1 CHCHD2P9 MAML3	1.39e-05	1434	128	19	EFO_0008354
Disease	Prostatic Neoplasms	MYC STAB2 ARID1A AR KMT2D ARID2 KMT2A ROBO1 EIF3A MUC4 MED12 NOL8	1.62e-05	616	128	12	C0033578
Disease	Malignant neoplasm of prostate	MYC STAB2 ARID1A AR KMT2D ARID2 KMT2A ROBO1 EIF3A MUC4 MED12 NOL8	1.62e-05	616	128	12	C0376358
Disease	Malignant neoplasm of breast	MICAL1 ABCA3 ZEB1 ELP1 ARID1A AR PHKB KMT2D FCRL3 CSF1R CLCA2 TREM1 ROBO1 DMD MED12 HNRNPR	1.74e-05	1074	128	16	C0006142
Disease	frontotemporal dementia and/or amyotrophic lateral sclerosis-2 (implicated_via_orthology)	CHCHD2 CHCHD2P9	5.59e-05	3	128	2	DOID:0060214 (implicated_via_orthology)
Disease	Parkinson's disease 22 (implicated_via_orthology)	CHCHD2 CHCHD2P9	5.59e-05	3	128	2	DOID:0080504 (implicated_via_orthology)
Disease	spinal muscular atrophy, Jokela type (implicated_via_orthology)	CHCHD2 CHCHD2P9	5.59e-05	3	128	2	DOID:0081356 (implicated_via_orthology)
Disease	Carcinoma, Granular Cell	MYC ARID1A KMT2A ROBO1 CA1	1.55e-04	116	128	5	C0205644
Disease	Adenocarcinoma, Tubular	MYC ARID1A KMT2A ROBO1 CA1	1.55e-04	116	128	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	MYC ARID1A KMT2A ROBO1 CA1	1.55e-04	116	128	5	C0205642
Disease	Carcinoma, Cribriform	MYC ARID1A KMT2A ROBO1 CA1	1.55e-04	116	128	5	C0205643
Disease	Adenocarcinoma, Basal Cell	MYC ARID1A KMT2A ROBO1 CA1	1.55e-04	116	128	5	C0205641
Disease	Adenocarcinoma	MYC ARID1A KMT2A ROBO1 CA1	1.55e-04	116	128	5	C0001418
Disease	Malignant Cystosarcoma Phyllodes	KMT2D MED12	1.85e-04	5	128	2	C0600066
Disease	Phyllodes Tumor	KMT2D MED12	1.85e-04	5	128	2	C0010701
Disease	magnesium measurement	DCDC1 TTC28 ITGA2 SGCZ	1.98e-04	66	128	4	EFO_0004845
Disease	Sezary Syndrome	ZEB1 ARID1A KMT2D	2.16e-04	27	128	3	C0036920
Disease	prostatic hypertrophy (implicated_via_orthology)	MYC AR	2.77e-04	6	128	2	DOID:11132 (implicated_via_orthology)
Disease	Squamous cell carcinoma of lung	BMP2K CSF1R WNK3	3.61e-04	32	128	3	C0149782
Disease	urate measurement, bone density	FNBP1 CLDN14 TTC28 NEDD9 TREM1 ROBO1 MAML2 TMEM178B CHCHD2P9 PRRC2B	3.80e-04	619	128	10	EFO_0003923, EFO_0004531
Disease	Liver carcinoma	MYC STAB2 ARID1A TTK AR ORC1 ARID2 KMT2A ROBO1	3.81e-04	507	128	9	C2239176
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	C5orf67 ACACB TSC22D2 ARID1A ZNF335 DOCK7	4.49e-04	224	128	6	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	SP4 C5orf67 ACACB ARID1A DOCK7 KLRG1	4.49e-04	224	128	6	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	SP4 C5orf67 ACACB ARID1A DOCK7 KLRG1	4.60e-04	225	128	6	EFO_0008317, EFO_0010351
Disease	Burkitt Lymphoma	MYC ARID1A KMT2A	5.13e-04	36	128	3	C0006413
Disease	Embryonal Rhabdomyosarcoma	ARID1A DMD	5.14e-04	8	128	2	C0206656
Disease	diverticular disease	IFNAR1 ELFN1 SCAPER MED12L ROBO1 LTBP1	5.91e-04	236	128	6	EFO_0009959
Disease	Intellectual Disability	TCF20 TFG ZNF335 SCAPER MED12L HTT HNRNPR CA8	7.65e-04	447	128	8	C3714756
Disease	theophylline measurement	ITGA2 NAV2	8.21e-04	10	128	2	EFO_0021180
Disease	response to hydrochlorothiazide, diastolic blood pressure change measurement	PKD1L1 SGCZ	8.21e-04	10	128	2	EFO_0005202, EFO_0006945
Disease	atopic dermatitis (implicated_via_orthology)	WASL NFKBIZ	1.00e-03	11	128	2	DOID:3310 (implicated_via_orthology)
Disease	cortical thickness	C5orf67 B4GALNT1 FBXL13 DCDC1 PCDHB11 TSC22D2 CRK DOCK7 NAV2 KMT2A ROBO1 QSER1 EPHA4	1.12e-03	1113	128	13	EFO_0004840
Disease	hepatocellular carcinoma (is_implicated_in)	ARID1A CSF1R FUBP1 ARID2 FES	1.18e-03	181	128	5	DOID:684 (is_implicated_in)
Disease	Male sterility	CDC14A AR KMT2D	1.20e-03	48	128	3	C0917731
Disease	Male infertility	CDC14A AR KMT2D	1.20e-03	48	128	3	C0021364
Disease	Subfertility, Male	CDC14A AR KMT2D	1.20e-03	48	128	3	C0848676
Disease	vitamin supplement exposure measurement, cleft lip	TTC28 SGCZ	1.20e-03	12	128	2	EFO_0003959, EFO_0009116
Disease	X-12063 measurement	CLDN14 WASL ARPP21 TDRD3 RBM38	1.33e-03	186	128	5	EFO_0021283
Disease	polyunsaturated fatty acids to total fatty acids percentage	C5orf67 ZNF335 DOCK7	1.35e-03	50	128	3	EFO_0022303
Disease	Coffin-Siris syndrome	ARID1A ARID2	1.41e-03	13	128	2	C0265338
Disease	HMG CoA reductase inhibitor use measurement	C5orf67 TSC22D2 ARID1A DOCK7 BAG6	1.43e-03	189	128	5	EFO_0009932
Disease	hair colour measurement	C5orf67 ARID1A LYST KMT2D FES MED12L QSER1 MYB EPHA4	1.49e-03	615	128	9	EFO_0007822
Disease	triglycerides in medium VLDL measurement	C5orf67 ARID1A DOCK7	1.77e-03	55	128	3	EFO_0022155
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	C5orf67 ACACB TSC22D2 DOCK7 HTT	1.84e-03	200	128	5	EFO_0004611, EFO_0020945
Disease	triglycerides in large VLDL measurement	C5orf67 ARID1A DOCK7	1.87e-03	56	128	3	EFO_0022178
Disease	triglycerides in very large VLDL measurement	C5orf67 ARID1A DOCK7	1.87e-03	56	128	3	EFO_0022325
Disease	platelet storage pool deficiency (implicated_via_orthology)	LYST DOCK7	1.89e-03	15	128	2	DOID:2223 (implicated_via_orthology)
Disease	African Burkitt's lymphoma	MYC ARID1A	1.89e-03	15	128	2	C0343640
Disease	Burkitt Leukemia	MYC ARID1A	1.89e-03	15	128	2	C4721444
Disease	hepatocellular carcinoma (is_marker_for)	MYC ARID1A TTK CSF1R FUBP1 ARID2	2.06e-03	301	128	6	DOID:684 (is_marker_for)
Disease	urate measurement, spine bone mineral density	NAV2 ROBO1 LTBP1	2.07e-03	58	128	3	EFO_0004531, EFO_0007701
Disease	Endometrial Neoplasms	MYC ZEB1 ARID1A	2.07e-03	58	128	3	C0014170
Disease	T-Cell Lymphoma	ARID1A KMT2D	2.15e-03	16	128	2	C0079772
Disease	triglycerides in VLDL measurement	C5orf67 ARID1A DOCK7	2.17e-03	59	128	3	EFO_0022326
Disease	triglycerides to total lipids in large HDL percentage	C5orf67 ARID1A DOCK7	2.28e-03	60	128	3	EFO_0022330
Disease	total lipids in VLDL measurement	C5orf67 ARID1A DOCK7	2.28e-03	60	128	3	EFO_0022314
Disease	Malignant Neoplasms	MYC ARID1A BIRC6 CSF1R	2.38e-03	128	128	4	C0006826
Disease	triglycerides in small VLDL measurement	C5orf67 ARID1A DOCK7	2.39e-03	61	128	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	C5orf67 ARID1A DOCK7	2.39e-03	61	128	3	EFO_0022274
Disease	Breast Carcinoma	ZEB1 ELP1 ARID1A AR KMT2D CSF1R MED12 HNRNPR	2.46e-03	538	128	8	C0678222
Disease	phospholipids in large VLDL measurement	C5orf67 ARID1A DOCK7	2.50e-03	62	128	3	EFO_0022169
Disease	triglycerides in medium LDL measurement	C5orf67 ARID1A DOCK7	2.50e-03	62	128	3	EFO_0022322
Disease	total lipids in very large VLDL measurement	C5orf67 ARID1A DOCK7	2.50e-03	62	128	3	EFO_0022313
Disease	phospholipids in very large VLDL measurement	C5orf67 ARID1A DOCK7	2.50e-03	62	128	3	EFO_0022299
Disease	free cholesterol measurement, very low density lipoprotein cholesterol measurement	SP4 C5orf67 ACACB ARID1A DOCK7	2.51e-03	215	128	5	EFO_0008317, EFO_0008591
Disease	triglycerides to total lipids in medium VLDL percentage	C5orf67 ZNF335 DOCK7	2.62e-03	63	128	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	C5orf67 ZNF335 DOCK7	2.62e-03	63	128	3	EFO_0022239
Disease	cholesteryl esters to total lipids in medium VLDL percentage	C5orf67 ZNF335 DOCK7	2.74e-03	64	128	3	EFO_0022253
Disease	cup-to-disc ratio measurement	DCDC1 TTC28 PRDM4 ELFN2 NEDD9 NAV2 KMT2A	2.78e-03	430	128	7	EFO_0006939
Disease	triglycerides in small LDL measurement	C5orf67 ARID1A DOCK7	2.86e-03	65	128	3	EFO_0022323
Disease	cholesterol in large VLDL measurement	C5orf67 ARID1A DOCK7	2.86e-03	65	128	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	C5orf67 ARID1A DOCK7	2.86e-03	65	128	3	EFO_0022230
Disease	osteoporosis (implicated_via_orthology)	MYC AR	3.04e-03	19	128	2	DOID:11476 (implicated_via_orthology)
Disease	total lipids in large VLDL	C5orf67 ARID1A DOCK7	3.12e-03	67	128	3	EFO_0022175
Disease	lung non-small cell carcinoma (is_implicated_in)	ARID1A KMT2D CSF1R BAG6	3.20e-03	139	128	4	DOID:3908 (is_implicated_in)
Disease	Vertigo	LRP12 ARPP21 SGCZ MED12L	3.20e-03	139	128	4	HP_0002321
Disease	Benign Neoplasm	MYC BIRC6 CSF1R	3.25e-03	68	128	3	C0086692
Disease	schizophrenia (implicated_via_orthology)	SP4 CSMD3 ELFN1	3.25e-03	68	128	3	DOID:5419 (implicated_via_orthology)
Disease	Neoplasms	MYC BIRC6 CSF1R	3.25e-03	68	128	3	C0027651
Disease	triglycerides to phosphoglycerides ratio	C5orf67 ARID1A DOCK7	3.25e-03	68	128	3	EFO_0022327
Disease	free cholesterol in large VLDL measurement	C5orf67 ARID1A DOCK7	3.25e-03	68	128	3	EFO_0022265
Disease	Bladder Neoplasm	MYC ARID1A KMT2D KMT2A	3.29e-03	140	128	4	C0005695
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	SP4 C5orf67 ACACB ARID1A DOCK7	3.29e-03	229	128	5	EFO_0004639, EFO_0008317
Disease	Deaf Mutism	CLDN14 CDC14A	3.37e-03	20	128	2	C4082305
Disease	Deafness, Acquired	CLDN14 CDC14A	3.37e-03	20	128	2	C0751068
Disease	Hearing Loss, Extreme	CLDN14 CDC14A	3.37e-03	20	128	2	C0086395
Disease	Complete Hearing Loss	CLDN14 CDC14A	3.37e-03	20	128	2	C0581883
Disease	Bilateral Deafness	CLDN14 CDC14A	3.37e-03	20	128	2	C3665473
Disease	Adenocarcinoma of prostate	MYC AR	3.37e-03	20	128	2	C0007112
Disease	Prelingual Deafness	CLDN14 CDC14A	3.37e-03	20	128	2	C0011052
Disease	attention deficit hyperactivity disorder (is_implicated_in)	AR CALY	3.37e-03	20	128	2	DOID:1094 (is_implicated_in)
Disease	Malignant neoplasm of urinary bladder	MYC ARID1A KMT2D KMT2A	3.37e-03	141	128	4	C0005684
Disease	stomach cancer (is_marker_for)	ARID1A KMT2D CSF1R FUBP1	3.46e-03	142	128	4	DOID:10534 (is_marker_for)
Disease	Colorectal Carcinoma	MYC UNC13B ABCA3 ARFGEF1 ARID1A CSMD3 TFG CDC14A DMD	3.60e-03	702	128	9	C0009402
Disease	skin hydration measurement	MYC PKD1L1	3.71e-03	21	128	2	EFO_0009586
Disease	HIV-1 infection, Susceptibility to viral and mycobacterial infections	NEDD9 NAV2	3.71e-03	21	128	2	EFO_0000180, Orphanet_391311
Disease	muscular dystrophy (implicated_via_orthology)	SGCZ DMD	3.71e-03	21	128	2	DOID:9884 (implicated_via_orthology)
Disease	triglyceride measurement, phospholipid measurement	C5orf67 ACACB TSC22D2 DOCK7	3.82e-03	146	128	4	EFO_0004530, EFO_0004639
Disease	Endometrial Carcinoma	MYC ZEB1 ARID1A	3.82e-03	72	128	3	C0476089
Disease	triglycerides to total lipids in small HDL percentage	C5orf67 ARID1A DOCK7	3.82e-03	72	128	3	EFO_0022336

Protein segments in the cluster

Peptide	Gene	Start	Entry
PGSNENSTQNVYKIP	TREM1	141	Q9NP99
QNQPPYEAIPQQINS	ELFN1	46	P0C7U0
SIDLPPLNSANNAQY	BIRC6	1941	Q9NR09
QGTLLSPNFPVNYNN	CSMD2	1106	Q7Z408
TNNEGILLSPNYPLN	CSMD3	1246	Q7Z407
FGQQKLYQVPNPQAA	NEDD9	86	Q14511
QEDPNYSPQRFPNAQ	BAG6	1111	P46379
ANSPLQYPLQGVEVQ	B4GALNT1	141	Q00973
SQPTTRNYPELNNNQ	CDC14A	521	Q9UNH5
YVNPNSQTTLGQEKP	ARFGEF1	631	Q9Y6D6
NQQITPGPAYSNRET	CEACAM8	86	P31997
QPAQQGQTYAPAIHQ	ARID2	931	Q68CP9
IQSENVPNATIYPGQ	ABCA3	46	Q99758
LEIYNQPNQEGPFDV	DMD	2351	P11532
AQHQPSQQQASPEYL	BMP2K	551	Q9NSY1
DITYQEPQGTQPAQQ	CHCHD2	96	Q9Y6H1
TQGSQGLPQQSYQQP	ARPP21	731	Q9UBL0
YAQPSVNTPLPNLQN	CRK	221	P46108
QPVLQQQGYIQQPSP	R3HDM1	626	Q15032
PQPAQQTGYQVIPNQ	R3HDM1	676	Q15032
AGTTFVQYQAPQLQP	RBM38	221	Q9H0Z9
SQNYGLVQPHNVPSI	QSER1	341	Q2KHR3
EELEPQDYQQSNQPG	NOBOX	501	O60393
PGGPNNNNYANVELI	ACACB	321	O00763
QAAYPQPQSQQSQQT	ARID1A	576	O14497
VPYSTGQGQPQQQQL	ARID1A	1391	O14497
QQAAQPSPQQDVYNQ	ARID1A	1416	O14497
QYVNNVNNGPTRPSE	PCDH19	1096	Q8TAB3
NLPYSQDKAQPGTTN	MUC16	14331	Q8WXI7
NATLNQYPPSINGGR	MUC4	4946	Q99102
QEIQGNPASPAQEYR	PSTPIP1	351	O43586
QRLQGSSINPPGLNY	DCDC1	536	M0R2J8
DQGQGLRQPYNATNP	LRP12	801	Q9Y561
LYQYSPQNQHVEQQP	NFKBIZ	286	Q9BYH8
VQQQASPYLQPLTGS	MED12L	1996	Q86YW9
QLSSNQPQQGVTPYG	MED12L	2126	Q86YW9
YPVQQVNQFQGSPQD	MAML3	796	Q96JK9
QQNPAPAGQVDYTKA	FUBP1	571	Q96AE4
NNPGVVNYSALPENE	BEND2	271	Q8NDZ0
VNGVSKYNPNPDQSV	EPHA4	416	P54764
NSNNPNPIISYDGVN	MLST8	71	Q9BVC4
PPENIEVSVQNQNYV	IFNAR1	231	P17181
PGQSQVSYQGLPVQK	LTBP1	516	Q14766
GEEILAQYLQQQQPG	MSTO1	446	Q9BUK6
LNYTKQNPATQNAPR	MYO18A	946	Q92614
SQPIAQQPLQQGGDY	HNRNPR	596	O43390
QGSIGLYTQNQPLPA	MED12	1836	Q93074
AQLQPNPPAQLANYE	MICAL1	196	Q8TDZ2
LTYQQNSATPVLGPN	ELP1	1276	O95163
GQLRQYDPPAESQQS	KLC3	151	Q6P597
QLPATGQPTVNNDYS	MYB	231	P10242
GYLVLDEEQQPSQPQ	AR	106	P10275
YIPVSQSASGLQQPQ	PRDM10	926	Q9NQV6
LPQNEQPYSTLVNNS	PTPDC1	6	A2A3K4
ANGPNYIQPQKRQTT	NOL8	636	Q76FK4
DQQEAVRQGQNPYPI	PLA2G4F	481	Q68DD2
PTKTQVGLIQYANNP	ITGA2	206	P17301
ELTNAQLQAQDYPSP	PTPN21	541	Q16825
GTNAQVNYSLLPPQD	PCDHB11	481	Q9Y5F2
PAAYTPNQSLQQAVG	MAML2	991	Q8IZL2
LQQAAQANDVPPFQY	ORC1	551	Q13415
GTNAQVNYSLLPPQD	PCDHB14	481	Q9Y5E9
DYQPNPEETLLQQNG	QTRT2	291	Q9H974
KYQQNVQSQPPRSGA	DNAJC5G	161	Q8N7S2
QGISQLPQYNNCPSP	ERVK-10	646	P87889
LPQYNNCPSPQAAVQ	ERVK-10	651	P87889
QGISQLPQYNNCPLP	ERVK-24	646	P63145
LPQYNNCPLPQAAVQ	ERVK-24	651	P63145
DIAYQEPQGTQPAQQ	CHCHD2P9	96	Q5T1J5
QPAQQQQPCFYGIKQ	CHCHD2P9	106	Q5T1J5
QGDIAQPLLQPNNYQ	CSF1R	956	P07333
TDNQYLGLQIGQPQD	HTT	586	P42858
ELPTATQAQNDYGPQ	KLRG1	11	Q96E93
QTEYQLSSPDQQNFP	CALY	51	Q9NYX4
YLSGHQPQNNNSPEL	C5orf67	106	F2Z3F1
NTSQLAFLLYNDQPP	DNASE2	86	O00115
QQKQNTPLETPVGYT	DOCK7	656	Q96N67
NDVVQNFYNPLLPSG	CLDN14	141	O95500
EPELQQYVPQLQNNT	EIF3A	421	Q14152
QSGLYDSQNPPTVNN	FNBP1	496	Q96RU3
VSQSLTPQQQPQYNL	FOXJ3	261	Q9UPW0
YPIANGNNQSPVDIK	CA1	21	P00915
FPDANGEYQSPINLN	CA8	41	P35219
VQIPYPLSENNQVQS	SQLE	206	Q14534
EEQQQPPQQQHYVGR	APBA1	36	Q02410
SKVQQQEYNTNDPPR	FBXL13	681	Q8NEE6
SPYEGENSSNIIPQQ	LYST	2081	Q99698
SNVNPGDSNPIYSQI	FCRL3	651	Q96P31
IQNQKYVPNSTDSPG	KMT2A	3041	Q03164
LAQTPGQAENQPYQP	SCAPER	1351	Q9BY12
NPYLIDPENQNVTLN	PKD1L1	2416	Q8TDX9
ETFYEQPPLVQQQGA	DBNL	341	Q9UJU6
NYSRNPTQSLEPNVG	FAM171B	476	Q6P995
NTYGIQTQTPQQVEP	PHKB	511	Q93100
TNNPSALDPYQSNGN	PRDM4	141	Q9UKN5
AQSAVVDEPNYQQPQ	FAM149B1	501	Q96BN6
LGASPYPNLSNQQTR	FES	756	P07332
VQTKNNTPIPYRNQG	MEIOC	481	A2RUB1
VEIPGLQLNNQDYFP	ATP6V1C2	401	Q8NEY4
VQNPSGSVQYQVIPQ	SP4	156	Q02446
VDPGFIYNNNNNLPL	TMEM178B	51	H3BS89
NPLPQGSVDYNNQKR	TDRD3	426	Q9H7E2
PVQPSGQSEYLQQHV	TSC22D2	371	O75157
LVVQTAQPDQPNYGF	LINC00869	101	P0C866
SQVLGVQNYASIPQP	SEC24A	1006	O95486
FYQQQQQSELQPPAP	MYC	31	P01106
QKAQDSYQTPQNPGI	SMG1	2231	Q96Q15
PQPQQQYNHPNTATV	NAV2	681	Q8IVL1
PYQIQELNASAPNDG	SLCO5A1	221	Q9H2Y9
YAEPVPENNALNTQT	ST6GALNAC1	76	Q9NSC7
PYFQSLNQQPREITN	RNF216	176	Q9NWF9
QQNNLPRTENAQLYP	SGCZ	11	Q96LD1
NPASEYVQQQPILQT	TSC22D1	651	Q15714
DPYNLPAQGQGNIII	TBC1D26	6	Q86UD7
QNVQGLYPQSPLLST	HERC2P3	351	Q9BVR0
IPNYNKPNPNQISVN	MTA1	356	Q13330
QPSGLTSQPQVLYQN	RIPK1	451	Q13546
QDNGYNGLLIAINPQ	CLCA2	36	Q9UQC9
YSQQTGPQQPQQFQG	TFG	276	Q92734
PIQILSNPLSTYNQQ	TMEM181	196	Q9P2C4
NNYGNNPLNSSLLPQ	ZNF808	206	Q8N4W9
PQTIPQQQSYQQAAA	PRRC2B	1941	Q5JSZ5
GPYTIFVPNNEALNN	STAB2	551	Q8WWQ8
YTPVLNQFPQELNVG	UNC13B	986	O14795
REGSQNLLFSYQPPQ	ROBO1	386	Q9Y6N7
PLGQQKQEVAPVQYN	ROBO1	1101	Q9Y6N7
EYPLNIQNINPSQGS	PKHD1L1	1996	Q86WI1
IQQPSQNLEYPLNPQ	UBQLNL	241	Q8IYU4
QLYQSHQPLPQATGQ	TCF20	186	Q9UGU0
TKLPLQSQVGQYNQP	TCF20	336	Q9UGU0
NYSLEQPSQLQVVPQ	ZEB1	476	P37275
AQSVSNALPLGYQQP	TTC28	1961	Q96AY4
LSTPYGQPACFQQQQ	TTK	481	P33981
NNYGNNPLNSSLLPQ	ZNF611	206	Q8N823
NPEITTNRFYGPQVN	WASL	166	O00401
QPQGNVPYLEAQKGQ	SIGLEC10	256	Q96LC7
YVPVSPGQQLVTQAQ	ZNF335	1276	Q9H4Z2
GSQQQALDLSVQYPP	SIGLEC11	341	Q96RL6
QNQPPYETIPQHINS	ELFN2	41	Q5R3F8
NNLYPNSSPGNRAIQ	VN1R2	301	Q8NFZ6
SNIPQAEVNVPGQIY	WNK3	601	Q9BYP7
LQQSQAVRQTPPYQE	KMT2D	4231	O14686
IGQPQNETPQPIYQN	NMNAT2	126	Q9BZQ4
NETPQPIYQNSNVAT	NMNAT2	131	Q9BZQ4